Concepedia

Michael LaMorte

ML

Statistics

Publications

6

Citations

295

H-Index

6

Active since

2013

Affiliations

Sanofi (France)(Current)

Sanofi (United States)

Gene Therapy Laboratory

Institute of Neuroimmunology of the Slovak Academy of Sciences

Cleveland Clinic

Michael LaMorte is an author at Sanofi (France) specializing in neuroscience, multiple sclerosis, and neuroimmunology.

Publications per year

2013–2025

6

Publications

6

RIPK1 activation mediates neuroinflammation and disease progression in multiple sclerosis

Matija Zelic, Fabrizio Pontarelli, Lisa Woodworth et al. · Cell Reports · 2021 · 137 citations · Full text

, , +17

Immune status following alemtuzumab treatment in human CD52 transgenic mice

Michael J. Turner, Michael LaMorte, Nathalie Chrétien et al. · Journal of Neuroimmunology · 2013 · 55 citations

, , +17

BTK regulates microglial function and neuroinflammation in human stem cell models and mouse models of multiple sclerosis

Ross C. Gruber, Gregory S. Wirak, Anna Blazier et al. · Nature Communications · 2024 · 40 citations · Full text

, , +17

Reduction of inflammation and preservation of neurological function by anti-CD52 therapy in murine experimental autoimmune encephalomyelitis

Michael J. Turner, Petti T. Pang, Nathalie Chrétien et al. · Journal of Neuroimmunology · 2015 · 27 citations · Full text

, , +17

Single-cell transcriptomic and functional studies identify glial state changes and a role for inflammatory RIPK1 signaling in ALS pathogenesis

Matija Zelic, Anna Blazier, Fabrizio Pontarelli et al. · Immunity · 2025 · 21 citations · Full text

, , +17

1–5 of 6